background image

26 

 

Table 11. Baseline Hemodynamic Values – FTW from CPB (G030052/S21) 

 

Variable  

Mean 

SD 

Median 

Min 

Max 

Systolic Blood 

Pressure (mmHg)  

30 

98.6 

23.2 

94.0 

58.0 

153.0 

Diastolic Blood 

Pressure (mmHg)  

30 

54.2 

12.7 

52.5 

22.0 

79.0 

Pulmonary Artery 

Systolic (mmHg)  

22 

37.3 

14.0 

36.0 

13.0 

58.0 

Pulmonary Artery 

Diastolic (mmHg)  

22 

22.9 

8.5 

22.0 

8.0 

39.0 

Central Venous 

Pressure 

(mmHg)  

26 

16.3 

8.0 

14.5 

6.0 

33.0 

Cardiac Output 

(LPM)  

11 

3.9 

1.3 

3.7 

2.6 

7.2 

Cardiac Index 

(L/min/m

2

)  

10 

1.6 

0.4 

1.6 

1.0 

2.0 

 

Table 12. Baseline Laboratory Values – FTW from CPB (G030052/S21) 

Variable

 

N

 

Mean

 

SD

 

Median

 

Min

 

Max

 

Blood Urea 

Nitrogen 

(mg/dl) 

32 

39.1 

21.3 

32 

12 

94 

Creatinine 

(mg/dl) 

32 

1.8 

0.8 

1.6 

0.9 

Total Bilirubin 

(mg/dl) 

31 

1.8 

1.8 

1.2 

0.4 

9.7 

aPTT (sec) 

29 

81.4 

60.7 

49.8 

23.4 

200 

PT (sec) 

31 

23.8 

17.8 

16.1 

11.6 

100 

INR 

31 

2.3 

2.3 

1.3 

0.9 

12.8 

Activated 

Clotting Time 

21 

294 

182 

174 

117 

640 

Red Blood Cells 

(x10

6

/ml) 

32 

4.6 

5.2 

3.5 

2.4 

32.6 

White Blood 

Cells (x10

3

/ml) 

32 

11.3 

5.5 

10.7 

28.2 

Platelets 

(x10

6

/ml) 

32 

152 

79.1 

173 

21 

369 

Hematocrit (%) 

32 

31.7 

6.5 

29.8 

23 

43.5 

SGOT (U/L) 

29 

344 

1071 

48 

16 

5766 

SGPT (U/L) 

31 

237 

586 

39 

13 

3125 

LDH (U/L) 

19 

1203 

1479 

678 

198 

5404 

Plasma Free 

Hemoglobin 

(mg/dl) 

20 

28.8 

28.9 

14.5 

3.1 

89 

Summary of Contents for CentriMag

Page 1: ...ENTRIMAG CIRCULATORY SUPPORT SYSTEM Abbott Medical Clinical Technical Support Phone number s United States Emergency HeartLine Support USA Tel 1 800 456 1477 Abbott Medical Main Switchboard Tel 1 925...

Page 2: ...3 Indicates a trademark of the Abbott group of companies Indicates a third party trademark which is property of its respective owner Pat http www abbott com patents 2019 Abbott All Rights Reserved...

Page 3: ...14 Intraoperative Device Management 15 Guidelines to Prevent Air Entrainment when Initiating Support 15 Patient Care and Management 15 Guidelines to Prevent Air Entrainment during Support 16 CentriMag...

Page 4: ...5 Safety and Effectiveness and Results 27 Device Malfunctions and Failures 30 Clinical Study Safety and Effectiveness Conclusions 33...

Page 5: ...ce The CentriMag Circulatory Support System is indicated for use as a right ventricular assist device Humanitarian Device The system when used as a right ventricular assist device is also authorized b...

Page 6: ...right ventricular assist device TEE transesophageal echocardiography TEG thromboelastography Description The CentriMag system is designed to provide a versatile and effective means for implementing me...

Page 7: ...t be set high enough to overcome native cardiac pressure in order to prevent retrograde flow Increasing the RPM will increase the flow of blood through the pump CAUTION If an increase in set speed doe...

Page 8: ...15 20 mmHg are suggestive of right ventricular dysfunction Such a condition is often associated with a decrease in right ventricular contractility and tricuspid insufficiency If adequate LVAD flow can...

Page 9: ...plies that may be used for this technique 4 CentriMag pumps Drainage cannulas Return cannulas 2nd Generation CentriMag console with motor and flow probe connected Standard 3 8 ID x 3 32 wall tubing Tw...

Page 10: ...echnique should be performed using aseptic techniques To prime the pump 1 Fill a large sterile basin with three liters of a warm balanced electrolyte solution 2 Slowly submerge one end of the drainage...

Page 11: ...ailable venous and arterial cannula may be used at the preference of the clinician For central cannulation it is advisable to use cannulas that are wire reinforced to resist kinking The drainage cannu...

Page 12: ...clamps are removed before the speed is set higher than 1000 RPMs there is a risk of retrograde flow NOTE If other manufacturers cannulas are used follow standard surgical techniques applicable to thos...

Page 13: ...tions above for left and right sided support See options above for left and right sided support Two cannulation approaches are shown in the figures below The left ventricle is drained via the left ven...

Page 14: ...E hemodynamic monitoring palpation and direct visualization of the heart will help to determine the volume of blood available for the circuit and the optimal level of flow After the chest is closed th...

Page 15: ...econds allowing the patient s vascular system to adjust between each RPM change The pump set speed should be gradually increased to the desired flow If flow drops or tubing chatter is observed the set...

Page 16: ...during insertion line chatter ramping of the flows or flow below the minimum alert Place a stopcock on the open ports of the central line to avoid air being entrained CAUTION Never leave any ports op...

Page 17: ...Wound sites should be carefully inspected for signs of tissue breakdown or excessive drainage Undue pressure or torque to the surgical site should be avoided in order to minimize trauma with special c...

Page 18: ...atient during transport Prior to shutting off the power supply and removal of the patient from the transport vehicle briefly unplug the console s power cord to confirm adequate battery charge and cons...

Page 19: ...d a decreased dependence on inotropic support Initial assessments of ventricular function should be made without increasing inotropic support IABP support or without volume loading of the ventricles E...

Page 20: ...5 The new tubing connectors are attached using a wet wet connection while taking care to eliminate air at the junction as well as in the circuit Secure these new connections with bands 6 Ensure that...

Page 21: ...ents suffering from post cardiotomy cardiogenic shock who were unable to be separated from CPB prior to leaving the operating room Clinical Inclusion Criteria Enrollment in the studies was limited to...

Page 22: ...pport Not applied to this study All possible measures have been attempted to correct low arterial pH arterial blood gas abnormalities electrolytes hypovolemia hypervolemia inadequate cardiac rate dysr...

Page 23: ...entriMag system removal Adverse events and complications were recorded throughout the duration of CentriMag system support through device removal and until the patient was discharged from the hospital...

Page 24: ...1 12 Patients N 32 26 12 25 Sex Male 24 75 15 58 8 67 20 80 Female 8 25 11 42 4 33 5 20 Race White 24 75 4 13 4 13 N A13 N A13 19 76 4 16 2 8 African American Other Age mean years SD 58 13 8 59 11 6 5...

Page 25: ...seline Laboratory Values FTW from CPB G030052 S21 Variable N Mean SD Median Min Max Blood Urea Nitrogen mg dl 32 39 1 21 3 32 12 94 Creatinine mg dl 32 1 8 0 8 1 6 0 9 4 Total Bilirubin mg dl 31 1 8 1...

Page 26: ...ut not identical across the studies so direct comparisons are not possible However the table shows that general trends in types and incidence of adverse events were similar across all four studies Tab...

Page 27: ...otension 1 1 3 5 5 19 2 2 17 0 0 0 8 8 8 Hepatic Dysfunction 1 1 3 8 7 27 3 2 17 0 0 0 12 10 11 Renal Failure Dysfunction 8 8 25 3 3 12 1 1 8 12 12 48 24 24 25 Neurologic Dysfunction 0 0 0 8 8 31 2 2...

Page 28: ...4 4 Other 1219 9 28 0 0 0 0 0 0 2120 10 40 33 19 20 19 Right arm compartment syndrome bronchorrhea and desaturation cardiogenic shock with suspected platelet dysfunction tear in ventricular tissue nea...

Page 29: ...valuate the safety of the device These data were obtained by analyzing adverse events associated with marketed CentriMag systems which were reported to Abbott Medical between June 1 2014 and June 30 2...

Page 30: ...he tables below Table 15 CentriMag Effectiveness in FTW Subjects from CPB Pivotal Study G030052 S21 Survival and Primary Endpoint Clinical Study N Survival to 30 Days Post device Survival To Discharge...

Page 31: ...y Endpoint Clinical Study N Survival to 30 Days Post device Survival to Discharge Primary Endpoint Success Cardiogenic Shock Trial G030052 22 26 11 26 42 Not Defined RVAS Trial G040029 23 12 7 12 58 N...

Page 32: ...ing acute myocardial infarction or post cardiotomy failure to wean from cardiopulmonary bypass and in patients with acute right ventricular failure from any cause In all studies the adverse event rate...

Reviews: